Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CTSA | P10619 | 7/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.35 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20607176 | 1.00 | FFAR1 (0.37) | FFAR1GAACTSAGRM2MMEL1 | |
| SCHEMBL20607466 | 0.88 | PDE4A (0.40) | GRM2LMNAMAPK1HTTMAPT | |
| SCHEMBL29628796 | 0.88 | PDE4A (0.40) | GRM2LMNAMAPK1HTTMAPT | |
| SCHEMBL20607335 | 0.85 | FFAR1 (0.36) | FFAR1GAACTSAGRM2MMEL1 | |
| SCHEMBL20607185 | 0.80 | GRM2 (0.35) | GRM2 | |
| SCHEMBL29628832 | 0.80 | GRM2 (0.35) | GRM2 | |
| SCHEMBL20607158 | 0.75 | IMPDH2 (0.35) | GAACTSA | |
| SCHEMBL5482341 | 0.74 | LMNA (0.47) | GAALMNAMAPK1HTTRAB9A | |
| SCHEMBL2843396 | 0.73 | HTT (0.60) | FFAR1LMNAMAPK1HTTRAB9A | |
| SCHEMBL20607313 | 0.73 | PDE4A (0.40) | GRM2LMNAHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108779076-B | 5-methyl-6-phenyl-4, 5-dihydro-2H-pyridazin-3-one derivatives | 大塚制药株式会社 | 2022-05-03 | — | — | CN | disclosed |